DBIA
AMGN icon

Dumont & Blake Investment Advisors’s Amgen AMGN Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$19K – 180
2019
Q1 		$19K Buy
+100
New +$19.1K 0.01% 173

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Dumont & Blake Investment Advisors's AMGN Position: Q2 2026 in Review

Dumont & Blake Investment Advisors reduced its Amgen (AMGN) stake by 7.6% in Q2 2026, selling an estimated $226K and leaving 8,006 shares worth $2.9M. The position accounts for 0.65% of the portfolio, ranked #38.

Dumont & Blake Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.6M in Q2 2024. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Dumont & Blake Investment Advisors held 8,006 shares of Amgen worth $2.9M as of Q2 2026.
  • Dumont & Blake Investment Advisors sold 660 Amgen shares in Q2 2026, an estimated $226K.
  • Amgen made up 0.65% of Dumont & Blake Investment Advisors's portfolio in Q2 2026, its #38 holding.
  • Dumont & Blake Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Dumont & Blake Investment Advisors's Amgen position peaked at $5.6M in Q2 2024.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.